Articles

Being physically fit may improve survival rates among diabetes patients with a particular type of heart abnormality….

Obese adults with poorly controlled type 1 diabetes can better control their blood sugar by adding liraglutide to their insulin therapy….

An experimental drug helped significantly more overweight patients with diabetes shed pounds, compared with placebo….

The diabetes drug sitagliptin appears to reduce the severity of reactive hypoglycemia….

Diabetes patients who responded to glucose-lowering treatment also improved their risk of adverse cardiovascular outcomes…. 

Closed-loop insulin delivery, also known as the “artificial pancreas,” may help improve overnight glycemic control in the youngest patients…. 

Empagliflozin reduced HbA1c, fasting plasma glucose and body weight when administered alone or as an add-on to metformin in patients with type 2 diabetes….  Adults with type 2 diabetes who had participated in one of two 12-week studies of empagliflozin (Boehringer Ingelheim, Eli Lilly) were treated for an additional 78 …

A nurse-led telephone intervention program for patients with diabetes resulted in a significant reduction in HbA1c levels, with successfully treated patients reporting reductions of more than 3.0% from baseline….

The higher the A1c the more cognitive decline was found, which means that having diabetes and poor glucose control may put older patients on a faster path to cognitive impairment….

Sitagliptin yielded similar glycemic results as sulfonylureas, but with less hypoglycemia and improvements in body weight among elderly patients with type 2 diabetes….